共 34 条
- [21] Prospective randomized single center study comparing the impact on long term renal transplant function of two prednisone-free maintenance immunosuppressive combinations with tacrolimus(Tac)/mycophenolate mofetil (MMF) versus tacrolimus/sirolimus (SLR). [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 288 - 288
- [25] A randomized, open-label study to compare the safety and efficacy of two different sirolimus (SRL) regimens with a tacrolimus (TAC) and mycophenolate mofetil (MMF) regimen in de novo renal allograft recipients: Renal function results from the Orion study [J]. TRANSPLANT INTERNATIONAL, 2007, 20 : 25 - 25
- [26] A randomized, open-label study to compare the safety and efficacy of two different sirolimus (SRL) regimens with a tacrolimus (Tac) and mycophenolate mofetil (MMF) regimen in de novo renal allograft recipients: Renal function results from the ORION study. [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 440 - 440
- [27] Influence of Immunosuppression, Donor Age, and Rejection on Chronic Banff Scores of 1 Year Protocol Biopsies in a Prospective Randomized Trial of Tacrolimus (TAC) plus Mycophenolate Mofetil (MMF) vs. Sirolimus (SRL) plus MMF Therapy Following Thymoglobulib (THY) Induction with Rapid Steroid Taper (RST). [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 259 - 259
- [28] A randomized, open-label study to compare the safety and efficacy of two different sirolimus (SRL) regimens with a tacrolimus (TAC) and mycophenolate mofetil regimen (MMF) in De novo renal allograft recipients: Acute rejection and graft survival results from the orion study [J]. TRANSPLANT INTERNATIONAL, 2007, 20 : 209 - 210
- [29] A randomized, open-label study to compare the safety and efficacy of two different sirolimus (SRL) regimens with tacrolimus (TAC) plus mycophenolate mofetil (MMF) in De Novo renal allograft recipients:: Preliminary 2-year safety results from the ORION trial [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 582 - 582
- [30] A randomized, open-label study to compare the efficacy and safety of two different sirolimus (SRL) regimens with tacrolimus (TAC) plus mycophenolate mofetil (MMF) in de novo renal allograft recipients: Preliminary 2-year efficacy results from the ORION trial [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 254 - 254